Effects of homocysteine on acetylcholine- and adenosine-induced vasodilatation of pancreatic vascular bed in rats

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 351-357

  Quere I ^b   Hillaire Buys, D ^a,c   Brunschwig, C ^a   Chapal, J ^a   Janbon, C ^b   Blayac, J P ^a   Petit, P ^a   Loubatieres Mariani M M ^a  

^a Faculté de Médecine   (France)

^b HÔPITAL SAINT ELOI   (France)

^c Institute of Biology   (France)

Author keywords

Acetylcholine; Adenosine; Endothelial cells; Homocysteine; Pancreatic vascular bed; Thiol; Vasodilatation

Indexed keywords

ACETYLCHOLINE; ADENOSINE; AMINO ACID; HOMOCYSTEINE; HYDROGEN PEROXIDE; SULFUR;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL COUNT; CELL CULTURE; CELL DAMAGE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW RATE; ILEUM; MALE; NONHUMAN; PANCREAS; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RISK FACTOR; UMBILICAL VEIN; VASCULAR DISEASE; VASCULAR LESION; VASCULAR RESISTANCE; VASODILATATION;

ACETYLCHOLINE; ADENOSINE; ANIMALS; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HUMANS; ILEUM; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PANCREAS; PERFUSION; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 0030760650     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701358     Document Type: Article

References (62)

1. + and calcium channels. Br. J. Pharmacol., 100, 427-434.
2. +]: a functional approach to separating EDRF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol., 21, 423-429.
3. 2-purinoceptor agonist, NECA, potentiates acetylcholine-induced glucagon secretion. Br. J. Pharmacol., 96, 500-502.
4. BOERS, G.H.J., SMALS, A.G.H., TRIJBELS, F.J.M., FOWLER, B., BAKKEREN J.A.J.M., SCHOONDERWALDT, H.C., KLELJER, W.J. & KLOPPENBERG, P.W.C. (1995). Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med., 313, 709-715.
5. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res., 72, 387-395.
6. CELERMAJER, D.S., SORENSEN, K., RYALLS, M., ROBINSON, J., THOMAS, O., LEONARD, J.V. & DEANFIELD, J.E. (1993). Impaired endothelium function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J. Am. Coll. Cardiol., 22, 854-858.
7. CHEN, G., SUZUKI, H. & WESTON, A.H. (1988). Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol., 95, 1165-1174.
8. CLARKE, R., DALY, L., ROBINSON, K., CAHALANE, E., FOWLER, B. & GRAHAM, I. (1991). Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Eng. J. Med., 324, 1149-1155.
9. COULL, B.M., MALINOW, M.R., BEAMER, N., SEXTON, G., NORDT, F. & DEGARMO, P. (1990). Elevated plasma homocyst(e)ine in acute stroke and TIA: a possible independent risk factor for stroke. Stroke, 21, 572-576.
10. 6, pyridoxal phosphate, and folate. Am. J. Cardiol., 75, 1107-1111.
11. DE GROOT, P.G., WILLEMS, C., BOERS, G.H.J., GONSALVES, M.D., VAN ADEN, W.G. & VAN MOURIK, J.A. (1983). Endothelial cell dysfunction in homocystinuria. Eur. J. Clin. Invest., 13, 405-410.
12. DEN HEIJER, M., BLOM, H.J., GERRITS, W.B.J., ROSENDAAL, F.R., HAAK, H.L. & WIJERMANS, P.W. (1995). Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet, 345, 882-885.
13. DEN HEIJER, M., KOSTER, T., BLOM, H.J., BOS, G.M.J., BRIËT, E., REITSMA, P.H., VANDENBROUCKE, J.P. & ROSENDAAL, F.R. (1996). Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis. N. Engl. J. Med., 334, 759-762.
14. FEELISH, M., TE POEL, M., ZAMORA, R., DEUSSEN, A. & MONCADA S. (1994). Understanding the controversy over the identify of EDRF. Nature, 368, 62-65.
15. FELETOU, M. & VANHOUTTE, P.M. (1988). Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol., 93, 515-524.
16. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
17. + conductance. Br. J. Pharmacol., 115, 1221-1230.
18. GLUECK, C.J., SHAW, P., LANG, J.E., TRACY, T., SIEVE-SMITH, L. & WANG, Y. (1995). Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am. J. Cardiol., 75, 132-136.
19. HAMMARSTRÖM, A.K.M., PARKINGTON, H.C. & COLEMAN, H.A. (1995). Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery. Br. J. Pharmacol., 115, 717-722.
20. HARKER, L.A., HARLAN, J.M. & ROSS, R. (1983). Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ. Res., 53, 731-739.
21. HARKER, L.A., ROSS, R., SLICHTER, S.J. & SCOTT, C.R. (1976). Homocysteine induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest., 58, 731-741.
22. HARKER, L.A., SLICHTER, S.J., SCOTT, C.R. & ROSS, R. (1974). Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med., 291, 537-543.
23. HEINECKE, J.W., ROSEN, H., SUZUKI, L.A. & CHAIT, A. (1987). The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem., 262, 10098-10103.
24. HILEY, C.R., BOTRILL, F.E., WARNOCK, J. & RICHARDSON, P.J. (1995). Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat. Br. J. Pharmacol., 116, 2641-2646.
25. 2y purinoceptor subtypes. Eur. J. Pharmacol., 199, 309-314.
26. JAFFE, E.A., NACHMAN, R.L., BECKER, C.G. & MINICK, C.R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52, 2745-2756.
27. KANG, S.S., WONG, P.W.K., COOK, H.Y., NORUSIS, M. & MESSER, J.V. (1986). Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J. Clin. Invest., 77, 1482-1486.
28. LANDGREN, F., ISRAELSSON, B., LINDGREN, A., HULTBERG, B., ANDERSSON, A. & BRATTSTRÖM, L. (1995). Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid. J. Intern. Med., 237, 381-388.
29. LENTZ, S.R., SOBEY, C.G., PIEGORS, D.J., BHOPATKAR, M.Y., FARACI, F.M. & MALINOW, M.R. (1996). Vascular dysfunction in monkeys with diet induced hyperhomocyst(e)inemia. J. Clin. Invest., 98, 24-29.
30. LOUBATIERES, A., MARIANI, M.M., DE MALBOSC, H., RIBES, G. & CHAPAL, J. (1969). Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia, 5, 1-10.
31. MALINOW, M.R. (1994). Homocyst(e)ine and arterial occlusive diseases. J. Intern. Med., 236, 603-617.
32. MCCULLY, K.S. (1971). Homocysteine metabolism in scurvy, growth and arteriosclerosis. Nature, 231, 391-394.
33. MCCULLY, K.S. & CARVALHO, A.C.A. (1987). Homocysteine thiolactone. N-homocysteine thiolactonyl retinamide, and platelet aggregation. Res. Commun. Chem. Pathol. Pharmacol., 56, 349-360.
34. MC CULLY, K.S. & WILSON, R.B. (1975). Homocysteine theory of arteriosclerosis. Atheroslerosis, 22, 215-227.
35. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology physiopathology and pharmacology. Pharmacol. Rev., 43, 109-142.
36. MUDD, S.H., FINKELSTEIN, J.D., IREVERRE, F. & LASTER, L. (1964). Homocystinuria: An enzymatic defect. Science, 17, 427-437.
37. MYERS, P.R., BANITT, P.F., GUERRA JR., R. & HARRISON, D.G. (1989). Characteristics of canine coronary resistance arteries: importance of endothelium. Am. J. Physiol., 257, H603-H610.
38. NYGARD, O., VOLLSET, S.E., REFSUM, H., STENSVOLD, I., TVERDAL, A., NORDREHAUG, J.E., UELAND, P.M. & KVALE, G. (1995). Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. J. Am. Med. Assoc., 274, 1526-1533.
39. OWEN, M.P. & BEVAN, J.A. (1985). Acetylcholine induced endothelial dependent vasodilatation increases as the artery diameter decreases in rabbit ear. Experientia, 41, 1057-1058.
40. PARÈS-HERBUTÉ, N., HILLAIRE-BUYS, D., ETIENNE, P., GROSS, R., LOUBATIERES-MARIANI, M.M. & MONNIER, L. (1996). Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 118, 783-789.
41. PERRY, I.J., REFSUM, H., MORRIS, R.W., EBRAHIM, S.B., UELAND, P.M. & SHAPER, A.G. (1995). Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet, 346, 1395-1398.
42. QUERE, I., HABIB, A., TOBELEM, G. & MACLOUF, J. (1995). Inhibition of cyclooxygenase activity in human endothelial cells by homocysteine. Adv. Prostaglandin-Tromboxane-Leukotriene Res., 23, 397-399.
43. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987). The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639-646.
44. RAMKUMAR, V., NIE, Z., RYBAK, L.P. & MAGGIRWAR, S.B. (1995). Adenosine, antioxidant enzymes and cytoprotection. Trends Pharmacol. Sci., 16, 283-285.
45. ROLLAND, P.H., FRIGGI, A., BERLATIER, A., PIQUET, P., LATRILLE, V., FAYE, M.M., GUILLOU, J., CHARPIOT, P., BODARD, H., GHIRINGHELLI, O., CALAF, R., LUCCIONI, R. & GARCON, D. (1995). Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation, 91, 1161-1174.
46. ROSS, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 362, 801-809.
47. RUBANYI, R.M.J. (1991). Endothelium-derived relaxing and contracting factors. J. Cell. Biochem., 46, 27-36.
48. SAÏAG, B., HILLAIRE-BUYS, D., CHAPAL, J., PAPE, D., RAULT, B., ALLAIN, H. & LOUBATERES-MARIANI, M.M. (1996). Study of the mechanisms involved in adenosine-5′-0-(2-thiodiphosphate) induced relaxation of rat thoracic aorta and pancreatic vascular bed. Br. J. Pharmacol., 118, 804-810.
49. SELHUB, J., JACQUES, P.F., BOSTOM, A.G., D'AGOSTINO, R.B., WILSON, P.W.F., BELANGER, A.J., O'LEARY, D.H., WOLF, P.A., SCHAEEFER, E.J. & ROSENBERG, I.H. (1995). Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med., 332, 286-291.
50. SELLKE, F.W., ARMSTRONG, M.L. & HARRISON, D.G. (1990). Endothelium dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation, 81, 1586-1593.
51. SHAO-ZENG, Z., LIPSKY, B.F., HSU, T. & HSU, I.C. (1990). Neutral red assay for cell viability and xenobiotic-induced cytotoxicity in primary cultures of human and rat hepatocytes. Cell. Biology Toxicol., 6, 219-234.
52. SOULAYMANI, R., GROSS, R., CHAPAL, J. & LOUBATIERES-MARIANI, M.M. (1985). Effet dilatateur de l'adénosine sur les vaisseaux du pancréas de rat. C. R. Soc. Biol., 179, 371-374.
53. STAMLER, J.S., OSBORNE, J.A., JARAKI, O., RABBANI, L.E., MULLINS, M., SINGEL, D. & LOSCALZO, J. (1993). Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest., 91, 308-318.
54. STAMPFER, M.J., MALINOW, M.D., WILLETT, W.D., NEWCOMER, L.M., UPSON, B., ULLMAN, D., TISHLER, P.V. & HENNEKENS, C.H. (1992). A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J. Am. Med. Assoc., 7, 877-881.
55. + channels in arterial smooth muscle. Science, 245, 177-180.
56. TAYLOR, S.G. & WESTON, A.H. (1988). Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci., 9, 272-274.
57. 2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol. Pharmacol., 44, 102-110.
58. TSAI, J.C., PERRELLA, M.A., YOSHIZUMI, M., HSIEH, C.M., HABER, E., SCHLEGEL, R. & LEE, M.E. (1994). Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc. Natl. Acad. Sci. U.S.A., 91, 6369-6373.
59. UPCHURCH JR., G.R., WELCH, G.N. & LOSCALZO, J. (1996). Homocysteine, EDRF and endothelial function. J. Nutr., 126, 1290S-1294S.
60. WALL, R.T., HARLAN, L.M., HARKER, L.A. & STRIKER, G.E. (1980). Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res., 18, 113-121.
61. ZAR, J.H. (1974). Multiple comparisons. In Biostatistical Analysis, ed. Zar, I.H. p. 151, Prentice Hall, N.J.: Englewood Cliffs.
62. 3 subtypes. Mol. Pharmacol., 40, 943-951.